Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹36Cr
Rev Gr TTM
Revenue Growth TTM
-176.98%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SEYAIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -89.3 | -87.2 | -69.8 | -82.3 | -37.6 | 27.0 | -25.5 | -100.0 | -434.4 | -100.0 | -100.0 | |
| 11 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
Operating Profit Operating ProfitCr |
| -345.3 | 45.1 | 67.3 | 20.8 | 27.9 | 18.8 | 57.0 | | 122.9 | | | |
Other Income Other IncomeCr | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 6 | 5 | 4 | 4 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 4 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 6 | 4 | 4 |
| -10 | -1 | -1 | -2 | -1 | -1 | -1 | -2 | -5 | -1 | -1 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
|
Growth YoY PAT Growth YoY% | -83.6 | -251.6 | 95.4 | 81.8 | 96.3 | 88.7 | -45.5 | 23.0 | -1,091.9 | -463.6 | -190.6 | 57.8 |
| -408.1 | -42.9 | -7.2 | -159.2 | -24.0 | -3.8 | -14.0 | | 85.6 | | | |
| -3.8 | -0.4 | -0.1 | -0.7 | -0.1 | 0.0 | -0.1 | -0.6 | -1.7 | -0.2 | -0.3 | -0.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 88.6 | 11.2 | 14.1 | 10.8 | 18.6 | -37.5 | -83.0 | 49.2 | -43.5 | -78.3 | -100.0 | |
| 214 | 227 | 240 | 242 | 275 | 190 | 45 | 56 | 54 | 4 | 5 | 3 |
Operating Profit Operating ProfitCr |
| 13.5 | 17.5 | 23.5 | 30.3 | 33.5 | 26.2 | -1.9 | 14.1 | -46.3 | 46.4 | | 163.5 |
Other Income Other IncomeCr | 1 | 2 | 1 | 1 | 2 | 9 | -92 | 1 | 9 | 9 | 15 | 19 |
Interest Expense Interest ExpenseCr | 10 | 13 | 14 | 18 | 18 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 11 | 11 | 14 | 15 | 16 | 17 | 18 | 18 | 18 | 18 | 18 | 19 |
| 14 | 26 | 47 | 74 | 106 | 52 | -110 | -7 | -26 | -5 | -8 | -9 |
| 1 | 0 | 5 | 21 | 18 | 5 | -1 | -1 | -1 | -2 | -2 | -2 |
|
| 288.3 | 105.5 | 57.7 | 24.1 | 68.9 | -46.9 | -333.1 | 94.3 | -292.9 | 85.9 | -81.7 | -4.3 |
| 5.3 | 9.7 | 13.4 | 15.1 | 21.4 | 18.2 | -249.0 | -9.6 | -66.5 | -43.1 | | 127.8 |
| 11.8 | 24.4 | 28.2 | 23.3 | 36.0 | 19.1 | -41.3 | -2.4 | -9.3 | -1.3 | -2.4 | -2.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 11 | 11 | 20 | 25 | 25 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| 54 | 78 | 280 | 716 | 801 | 945 | 835 | 829 | 805 | 801 | 795 | 793 |
Current Liabilities Current LiabilitiesCr | 65 | 62 | 87 | 117 | 65 | 97 | 98 | 95 | 91 | 91 | 90 | 91 |
Non Current Liabilities Non Current LiabilitiesCr | 339 | 416 | 334 | 458 | 619 | 704 | 764 | 693 | 693 | 694 | 696 | 696 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 109 | 148 | 141 | 188 | 184 | 203 | 88 | 55 | 32 | 29 | 27 | 25 |
Non Current Assets Non Current AssetsCr | 511 | 570 | 650 | 1,128 | 1,430 | 1,570 | 1,636 | 1,588 | 1,583 | 1,583 | 1,581 | 1,582 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 14 | 16 | 69 | 74 | 95 | 2 | -9 | 12 | 1 | -10 | -17 |
Investing Cash Flow Investing Cash FlowCr | -59 | -71 | -137 | -169 | -287 | -84 | 7 | -7 | -4 | 9 | 15 |
Financing Cash Flow Financing Cash FlowCr | 31 | 55 | 68 | 109 | 180 | 81 | 2 | -5 | 3 | 1 | 2 |
|
Free Cash Flow Free Cash FlowCr | 14 | 16 | 69 | 74 | 95 | -92 | -8 | 13 | 1 | -10 | -17 |
| 104.8 | 58.1 | 163.2 | 140.7 | 106.9 | 3.2 | 8.2 | -193.0 | -2.6 | 302.3 | 270.9 |
CFO To EBITDA CFO To EBITDA% | 40.8 | 32.3 | 93.2 | 69.9 | 68.4 | 2.2 | 1,091.7 | 130.7 | -3.8 | -280.9 | 321.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 151 | 607 | 1,430 | 1,127 | 104 | 133 | 94 | 57 | 52 | 35 |
Price To Earnings Price To Earnings | 0.0 | 6.0 | 14.4 | 27.3 | 12.7 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.6 | 1.9 | 4.1 | 2.7 | 0.4 | 3.0 | 1.4 | 1.5 | 6.5 | |
Price To Book Price To Book | 0.0 | 1.7 | 1.6 | 1.9 | 1.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| 5.5 | 11.1 | 13.4 | 18.4 | 12.8 | 12.9 | -1,090.9 | 92.5 | -48.0 | 220.0 | -151.7 |
Profitability Ratios Profitability Ratios |
| 17.8 | 21.2 | 26.9 | 41.9 | 49.7 | 42.5 | 37.9 | 55.3 | 7.5 | 100.0 | |
| 13.5 | 17.5 | 23.5 | 30.3 | 33.5 | 26.2 | -1.9 | 14.1 | -46.3 | 46.4 | |
| 5.3 | 9.7 | 13.4 | 15.1 | 21.4 | 18.2 | -249.0 | -9.6 | -66.5 | -43.1 | |
| 9.4 | 8.2 | 8.9 | 7.2 | 8.4 | 3.4 | -6.8 | -0.5 | -1.6 | -0.3 | -0.5 |
| 20.0 | 30.1 | 14.1 | 7.1 | 10.7 | 4.8 | -12.7 | -0.7 | -3.0 | -0.4 | -0.8 |
| 2.1 | 3.7 | 5.3 | 4.0 | 5.5 | 2.6 | -6.4 | -0.4 | -1.5 | -0.2 | -0.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Seya Industries Ltd** is an Indian specialty chemical manufacturer currently navigating a complex **Corporate Insolvency Resolution Process (CIRP)**. Historically a significant player in the benzene-based chemistry space, the company is presently focused on operational survival, debt restructuring, and the preservation of its integrated manufacturing assets.
---
### **Core Manufacturing Competencies & Integrated Value Chain**
The company specializes in the manufacture of **Specialty Chemical Intermediates** and **Organic Chemical Intermediates**. Its business model is built on a **backward and forward integrated** structure designed to convert base chemicals into high-margin downstream products.
* **Niche Chemistries:** The company possesses the technical expertise to execute complex and hazardous chemical processes at scales ranging from **kilograms to several tons**.
* **Technology Moat:** Seya utilizes specialized know-how licensed from **German technology suppliers**, protected by **20-year confidentiality agreements**.
* **Strategic Integration:** The manufacturing facility is designed for captive consumption; **50%** of proposed greenfield capacity is intended for internal use, positioning the company as a potential **lowest-cost producer** through value-chain optimization.
* **Manufacturing Base:** Operations are centered at **T-13/T-14, Tarapur Industrial Area, MIDC, Boisar (Maharashtra)**.
---
### **Diversified End-User Applications**
Seya’s product portfolio serves a broad spectrum of essential and industrial global sectors:
| End-User Segment | Key Applications & Products |
| :--- | :--- |
| **Agrochemicals** | Insecticides and Pesticides (e.g., **DDT**, **Quinalphos**, **Mortein**, **Baygon**) |
| **Pharmaceuticals** | Intermediates for **Paracetamol** and **Floxacins** |
| **Personal & Health Care** | Ingredients for **Hair dyes** and hygiene products |
| **Printing & Pigments** | **Computer Printing Inks**, **Laser/Inkjet inks**, Paints, and **Road Markings** |
| **Industrial & Textiles** | **Thermic fluids** (heating mediums), **Rubber chemicals**, and **Textile dyes** |
---
### **Current Operational Status & Capacity Constraints**
Manufacturing operations are **presently suspended** or severely restricted due to a combination of financial and regulatory factors:
* **Liquidity Crunch:** A severe paucity of working capital has halted active production.
* **Environmental Restrictions:** Prior to suspension, operations were limited to **30–40% capacity utilization** due to effluent discharge limits imposed by the **National Green Tribunal (NGT)**.
* **ZLD Transition:** A priority strategic goal is the implementation of **Zero Liquid Discharge (ZLD)** technology to bypass current NGT restrictions and resume full-scale production.
---
### **Financial Performance & Solvency Metrics**
The company has experienced a sharp decline in revenue and persistent losses, exacerbated by the classification of its credit facilities as **Non-Performing Assets (NPA)**.
| Metric (₹ in Lakhs) | FY 2024-25 (Est/Interim) | FY 2023-24 (Audited) | FY 2022-23 (Audited) |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | *Monitoring* | **1,713.64** | **4,615.16** |
| **Revenue from Operations** | *Monitoring* | **805.84** | **3,711.22** |
| **Profit / (Loss) After Tax** | **(630.69)** | **(345.39)** | **(2,467.98)** |
| **Basic EPS (₹)** | *Monitoring* | **(1.31)** | **(9.29)** |
| **Total Assets** | **1,61,231.77** | **1,61,231.77** | **1,64,364.23** |
*Note: FY 2024-25 figures reflect the ongoing monitoring period under CIRP.*
---
### **Insolvency Status & Governance Under CIRP**
Seya Industries is currently under the **Corporate Insolvency Resolution Process (CIRP)** following an order by the **Hon’ble NCLT (Mumbai Bench)** on **November 2, 2023**.
* **Leadership:** The powers of the Board of Directors are **suspended**. Operations are managed by the **Interim Resolution Professional (IRP)**, Mr. Bhavesh Rathod, to maintain the company as a **"Going Concern."**
* **Legal Stay:** The **NCLAT** issued a stay on the constitution of the **Committee of Creditors (CoC)** on **December 6, 2024**, which remains in force as of **September 2025**.
* **Management Continuity:** Despite the CIRP, **Mr. Ashok G Rajani** was re-appointed as Managing Director & CEO for a **5-year term** (2024–2029) to provide technical and strategic continuity.
---
### **Debt Profile & Interest Non-Provision Dispute**
A significant portion of the company’s financial distress stems from a protracted legal battle with its lenders regarding committed funding for expansion.
* **Unprovided Interest:** The company has **ceased providing for interest costs** on several credit facilities, arguing that lenders failed to fulfill lending obligations.
* **Contingent Liabilities:** As of March 31, 2025, unprovided interest amounted to **₹14,260.77 Lakhs**. If these contractual interests were recognized, total liabilities would escalate to **₹1,59,972.84 Lakhs**.
* **Default Status:** Principal outstanding in default includes **₹69,601.68 Lakhs** in Term Loans and **₹7,696.65 Lakhs** in Working Capital.
---
### **Strategic Turnaround & Growth Catalysts**
Management’s recovery strategy focuses on cost rationalization and capitalizing on structural shifts in the global chemical market:
* **Mega Green-Field Project:** A **₹600 crore** investment at MIDC Tarapur is currently on hold. Once operational at **80% capacity**, it is projected to generate **₹1,000–1,200 crore** in annual revenue.
* **Austerity Measures:** Implementation of **workforce rationalization**, **pay cuts**, and the suspension of all **discretionary capital expenditure** to preserve cash.
* **"China Plus One" Opportunity:** The company aims to capture market share as global buyers diversify away from China due to rising costs and environmental crackdowns.
* **Import Substitution:** Aligning with **"Make in India"** initiatives to replace imported chemical intermediates with locally manufactured alternatives.
---
### **Critical Risk Factors for Investors**
* **Going Concern Uncertainty:** Auditors have repeatedly highlighted material uncertainty regarding the company’s ability to continue operations, as current liabilities exceed current assets by **₹6,394.99 Lakhs**.
* **Regulatory & Legal Headwinds:** The company faces a **SEBI Final Order** (issued May 2, 2025), currently under an interim stay by the **Securities Appellate Tribunal (SAT)**.
* **Macroeconomic Volatility:** The **Russia-Ukraine war** and recessionary trends in **Europe and the US** have led to volatile raw material costs and a decline in global demand for specialty intermediates.
* **Operational Hazards:** High exposure to environmental regulations regarding hazardous waste and effluent treatment; failure to meet **Zero Liquid Discharge** targets could permanently impair production capacity.